Consultation on a Budget Impact Analysis Tool
Current consultation status: Closed
Consultation period: January 25 to February 22, 2024
CADTH is taking steps to help drug sponsors enhance the budget impact analyses (BIAs) included in the submissions they file with our Drug Reimbursement Review program.
Coming Soon: CADTH's 2024 Call for Nominations
Call for Nominations: Expert and Advisory Committee Members
Coming Soon!
The 2024 call for nominations will be open from March 4, 2024, to April 2, 2024. Please note the dates and length of the nominations window this year.
CADTH to Become the Canadian Drug Agency
As announced on December 18 by the Government of Canada, CADTH will become the Canadian Drug Agency (CDA).
The Government of Canada Announces the Creation of the Canadian Drug Agency
December 18, 2023 | Ottawa, Ontario | Health Canada
Helping make Canada's drug system more sustainable and better prepared for the future
Canadians should be able to appropriately access and afford the prescription drugs they need. However, many Canadians are left vulnerable due to high drug costs, inaccessible health data, and the lack of consistent standards for prescribing practices.